can have more than one outcome:  

  • Remission – This means there is no evidence of disease – sometimes people call it “dancing with NED”. Normal CA125 test results, CT scans, and physical exams can indicate you are in remission. This could last for months or years. Some finish their frontline treatment and never deal with this disease again.  
  • Stable disease – This means that the cancer is still present (probably reduced in size) and scans and tests reveal no change in your condition over time.  
  • Disease progression – This means the cancer is growing. If disease progression happens during or soon after treatment, your doctors may change your treatment plan. If disease progression happens after a period of remission, it is called a recurrence. 

When your treatment is over, you may experience feelings of insecurity and loneliness, and fear of recurrence. You may also feel a need to  take responsibility for your health.

If you are worried and stressed, there is information and support which may help.

Two women with glasses looking over something on a computer screen

Follow up tests

Follow-up tests and treatments will vary once your treatment is complete.

You will have scheduled visits with your doctor to:
- monitor your response to treatment
- recognize and immediately deal with any treatment-related complications
- monitor for a recurrence of the cancer

The frequency of visits will vary according to your specific situation, although a general guideline is:
- year 1: every 3 months
- years 2-3: every 4 months
- years 4-5: every 6 months
- years 5+: annually

It is your right to understand how your follow-up care has been planned and how you are being monitored for recurrence. Be sure to talk to your doctor about what to expect, and ask any questions you may have about how decisions about your care are being made.

CA125 blood test

Some people with ovarian cancer will experience an increase in their CA125 levels, while others will not. While CA125 level may be elevated, you might be feeling well and be without symptoms.

A rising CA125 does not always mean that treatment should begin again. Research shows that starting treatment for recurrence early based on an increasing CA125 does not lead to better survival outcomes, and may actually decrease quality of life. Whether to use the CA125 or to monitor for possible recurrence on the basis of symptoms needs to be discussed with your gynecologic oncologist. Together you will decide whether or not to regularly monitor your CA125 and if so, what steps will be taken if your CA125 begins to rise (this might be a “watchful waiting” approach, or beginning treatment).

Learning to manage your fear of cancer recurrence

Learn from clinical psychologist, Dr. Sophie Lebel, about how to manage fear of recurrence


When cancer returns after a period of remission, it is considered a recurrence.

Many people with ovarian cancer experience a recurrence or multiple recurrences. For those who have experienced a recurrence, it may be helpful to think of ovarian cancer as a chronic disease that will need to be managed.


If you have been diagnosed with a recurrence, there are many supports available to you, including ‘Understanding ovarian cancer: A comprehensive patient guide’.

Woman wearing pink headscarf talks with her doctor with someone to support her

Treatment for recurrence

 Treatment options for recurrence may include: 

  • use of chemotherapydrugs  
  • use of other drugs like PARP inhibitors or  angiogenic inhibitors 
Some considerations regarding treatment of recurrence include: 
  • Length of time from the finish of the first treatment series to recurrence (also called progression free survival).
    •  if the cancer recurs in less than 6 months  following the standard taxol and carboplatin regimen, it is likely that and that alternatives to platinum drugs will be needed to treat the recurrence.
    • if it is 6 – 12 months  from completion of treatment to recurrence, platinum drugs may be considered again.
    • if it is more than 12 months, platinum drugs are likely to be used again. Platinum drugs are usually the first choice, and if there is a a number of regimens are considered. 
  • Consideration of side effects, such as neuropathy, also needs to be given to the choice of chemotherapy drugs. 
  • Clinical trialsmay be an option to be explored. 
  • is not usually given in recurrence because of the possibility of surgical adhesions, sometimes referred to as scar tissue, that limit its effectiveness. 
  • is an option if it has been and the new disease is only in one area. If there has been then, depending upon where the spread is, surgery may or may not be an option. 

Other issues

Palliative care

Palliative care is specialized health care for individuals that focuses less on curing disease, and more on promoting a high quality of life, reducing/managing symptoms, providing spiritual, psychological, emotional, and social support, and offering similar supports to loved ones and caregivers. It may be combined with other treatments aimed at reducing or managing the illness. In some cases, palliative care is necessary to ensure a peaceful, dignified, and self-determined dying process, and will provide grieving support for loved ones and caregivers. Ultimately, the goal of palliative care is to provide comfort and dignity for the person living with the illness as well as the best quality of life for both this person and their family and friends. 

Woman wearing pink headscarf talks with her doctor

Palliative care can be offered at home, in hospitals, in long-term care facilities, and/or in hospices.

You may find the following videos of Ovarian Cancer Canada Speaker Series helpful

Unpacking palliative: The myths and the realities

Enhance your understanding of palliative care by unpacking the concept and clearing up common myths.

Living with the fear of dying

This presentation lead by Jennifer de Wet Turner, registered psychotherapist and certified spiritual care practitioner, focuses on how to create a safe space to talk about dying, spiritual and emotional healing, and how to facilitate peace.

Living with resilience in the face of uncertainty

Roy Ellis' presentation provided insights into coping with a diagnosis and finding a path to awareness and opportunities for growth. He also shared strategies for dealing with anxiety and depression.